Palladium Seed Model 100
FDA 510(k) K852542 · Nuclear Medicine, Inc.
510(k) numberK852542
Submission
- Device name
- Palladium Seed Model 100
- Applicant
- Nuclear Medicine, Inc.
Atlanta, GA, US - Received
- June 14, 1985
- Decision date
- January 14, 1986
- Decision
- Substantially Equivalent (SESE)
- Type
- Traditional 510(k)
Other 510(k)s with product code IWI
| 510(k) | Device | Applicant | Decision |
|---|---|---|---|
| K973363 | North American SCIENTIFIC(NASI)PD-103 Radionuclide Brachytherapy Source-Model MED3633IWI · Traditional | Ml Strategies, Inc. | 07/02/1998SE |
| K940632 | I-125 Rapid StrandIWI · Traditional | Medi-Physics Inc. Dba Nycomed Amersham Imaging | 09/02/1994SE |
| K912170 | Radioactive IODINE-125 SourcesIWI · Traditional | Best Industries | 08/09/1991SE |
| K882449 | Cesium 137 Source, Model CSM-40IWI · Traditional | Cis-Us, Inc. | 04/14/1989SE |
| K874787 | Modified Palladium Seed Model 100IWI · Traditional | Theragenics Corp. | 12/22/1987SE |
Questions and answers
When was Palladium Seed Model 100 cleared by the FDA?
Palladium Seed Model 100 (K852542) received a 510(k) decision of Substantially Equivalent on January 14, 1986, 214 days after the submission was received.
What is the product code of K852542?
The FDA product code is IWI – Source, Isotope, Sealed, Gold, Titanium, Platinum, a Class II (moderate risk) device regulated under 21 CFR 892.5730.